Preclinical evaluation of monkeys of a ribavirin regimen proposed for use in Lassa fever patients.
D000818:Animals; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D004906:Erythrocyte Count; D005260:Female; D006400:Hematocrit; D006452:Hemoglobinometry; D007835:Lassa Fever / Q000188:drug therapy*; D007958:Leukocyte Count; D008214:Lymphocytes / Q000187:drug effects; D008253:Macaca mulatta; D008297:Male; D010976:Platelet Count; D012156:Reticulocytes / Q000187:drug effects; D012254:Ribavirin / Q000008:administration & dosage*; D012263:Ribonucleosides / Q000008:administration & dosage*
D012263:Ribonucleosides; D012254:Ribavirin